Avadel Pharmaceuticals plc ( AVDL) - Stock Earnings

AVDL Quarterly earnings

DateEarningsRevenue
2025Q1 -4.9 million USD 52.5 million USD
2025Q2 9.7 million USD 68.1 million USD
2025Q3 20000 USD 77.5 million USD

AVDL Yearly earnings

DateEarningsRevenue
2022 -137.5 million USD 1.5 million USD
2023 -160.3 million USD 28.0 million USD
2024 -48.8 million USD 169.1 million USD

AVDL

Price: $21.64

52 week price:
6.38
23.57

Earnings Per Share: -0.02 USD

P/E Ratio: -1084.50

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Ireland

Volume: 237800

Ebitda: 27.2 million

Market Capitalization: 2.1 billion

Links: